国际麻醉学与复苏杂志   2020, Issue (9): 8-8
    
右美托咪定滴鼻应用于超声引导下臂丛神经阻滞的效果观察
龙焱, 李静静, 马舒玉, 谈诚, 王志萍1()
1.徐州医科大学麻醉学专业在读研究生
Observation of the effect of intranasal dexmedetomidine on ultrasound‑guided brachial plexus block
 全文:
摘要:

目的 研究右美托咪定(dexmedetomidine, Dex)滴鼻对成年人上肢手术超声引导下臂丛神经阻滞镇静镇痛效果以及对术中血流动力学的影响。 方法 选择择期行超声引导下臂丛神经阻滞的上肢手术患者60例,按随机数字表法分为Dex滴鼻组(D组)和对照组(C组),每组30例。D组患者麻醉前30 min采用黏膜雾化装置进行1 μg/kg Dex(100 mg/L)原液滴鼻,C组以同样方式滴入等容量的生理盐水,两组患者均在超声引导下予0.33%罗哌卡因+1%利多卡因混合液20 ml行肌间沟臂丛神经阻滞。记录入室后(T0)、臂丛穿刺前(T1)、臂丛穿刺时(T2)、臂丛穿刺后(T3)、切皮时(T4)及手术开始后20 min(T5)的MAP、心率、SpO2及Ramsay镇静评分,记录T2和T4时的VAS评分,记录术中芬太尼使用情况,记录心动过缓、低血压、恶心呕吐、呼吸抑制等不良反应发生情况,术后随访患者并记录麻醉满意度评分。 结果 两组患者各时点SpO2差异无统计学意义(P>0.05);T0时,两组患者MAP、心率、Ramsay镇静评分差异无统计学意义(P>0.05)。与T0时比较,T1~T5时:D组MAP、心率降低,Ramsay镇静评分升高(P<0.05);C组MAP、心率及Ramsay镇静评分差异无统计学意义(P>0.05)。与C组比较,T1~T5时,D组MAP、心率明显降低(P<0.05),Ramsay镇静评分明显升高(P<0.05)。D组T2和T4时VAS评分低于C组(P<0.05),术中芬太尼用量明显低于C组(P<0.05)。两组患者低血压、心动过缓、恶心呕吐等不良反应发生率差异无统计学意义(P>0.05)。D组患者术后麻醉满意度高于C组(P<0.05)。 结论 在上肢手术中,超声引导下臂丛神经阻滞30 min前应用黏膜雾化装置进行1 μg/kg Dex滴鼻,可以起到良好的镇静镇痛效果,稳定血流动力学,减少麻醉性镇痛药的用量,提高患者的舒适度,同时不良反应少。

关键词: 右美托咪定; 滴鼻; 臂丛神经阻滞; 超声引导
Abstract:

Objective To investigate the sedative, analgesic and hemodynamic effects of intranasal dexmedetomidine (Dex) on ultrasound‑guided brachial plexus block during the upper limb surgery in adults. Methods Sixty patients, scheduled for elective upper limb surgery under ultrasound‑guided brachial plexus block were recruited and equally divided into intranasal Dex group (group D) and control group (group C) using a random number table method, 30 cases in each group. Patients in group D received intranasal Dex of 1 μg/kg (100 mg/L) via a mucosal atomization device (MAD) 30 min before anesthesia, while patients in group C received volume‑matched intranasal normal saline over the same period. All patients then underwent ultrasound‑guided interscalene brachial plexus block with a 20 ml mixture of 0.33% ropivacaine and 1% lidocaine. Measurements included mean arterial pressure (MAP), heart rate, pulse oxygen saturation (SpO2) and Ramsay Sedation Scale scores at the time of entering room (T0), before plexus block (T1), during plexus block (T2), after plexus block (T3), skin incision (T4), and 20 min after the start of surgery (T5). The Visual Analogue Scale (VAS) scores of pain at T2 and T4 were observed. The use of fentanyl during the operation and the adverse reactions such as bradycardia, hypotension, nausea, vomiting and respiratory depression were recorded. The satisfaction scores of patients about anesthesia after surgery were also recorded. Results There is no significant differences in SpO2 at all time points between two groups (P>0.05). At the time of T0, no significant differences were found in MAP, heart rate, Ramsay Sedation Scale scores between two groups (P>0.05). Compared with T0, patients in group D had lower MAP, lower heart rate and higher Ramsay Sedation Scale scores at the time of T1‒T5 (all P<0.05), while there were no significant differences in group C (P>0.05). Compared with group C, patients in group D showed lower MAP, lower heart rate and higher Ramsay Sedation Scale scores at the time of T1‒T5 (all P<0.05). The VAS scores of pain at T2 and T4 and the total amount of fentanyl during the operation were significantly lower in group D (P<0.05). There were no significant differences in the incidence of adverse events such as hypotension, bradycardia, nausea and vomiting between the two groups (P>0.05). The satisfaction scores of patients about anesthesia in group D were also significantly higher than group C (P<0.05). Conclusions For patients undergoing upper limb surgery, intranasal Dex of 1 μg/kg via a MAD 30 min before ultrasound‑guided brachial plexus block could provide excellent sedation and analgesia, stabilize hemodynamics, decrease the consumption of analgesics, and improve the patient's level of comfort, without inducing any adverse effects.

Key words: Dexmedetomidine; Intranasal administration; Brachial plexus block; Ultrasonic guidance